Frontoparietal cavernous malformation in a 39-year-old woman: a case report
Article Sidebar
Main Article Content
Abstract
Cerebral cavernous malformation (CCMs) is an angiographically occult, low-flow neurovascular disease resulting from capillary dilatation of cerebral blood vessels that may also occur in the spinal cord, causing extravasation of blood cells from the affected vessel that leads to multiple repercussions in the patient’s life. This condition’s clinical characteristics include recurrent bleeding, seizures, persistent neurological deficits, epilepsy, and death. In this study, we describe the clinical course of a patient with a Cavernous Malformation and its prognosis regarding the association between clinical progression and therapeutic perspectives. It's relevant to elucidate possible lack of studies that may urge further research on this theme and new learning pathways should be opted for to increase awareness of this condition in order to improve its prognosis.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Awad IA, Polster SP. Cavernous angiomas: deconstructing a neurosurgical disease. J Neurosurg. 2019 Jul 1;131(1):1-13. doi: 10.3171/2019.3.JNS181724. PMID: 31261134; PMCID: PMC6778695.
McKerracher L, Shenkar R, Abbinanti M, Cao Y, Peiper A, Liao JK, Lightle R, Moore T, Hobson N, Gallione C, Ruschel J, Koskimäki J, Girard R, Rosen K, Marchuk DA, Awad IA. A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease. Transl Stroke Res. 2020 Jun;11(3):365-376. doi: 10.1007/s12975-019-00725-8. Epub 2019 Aug 24. PMID: 31446620; PMCID: PMC7036327.
Flemming KD, Kumar S, Brown RD Jr, Lanzino G. Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations. World Neurosurg. 2020 Jan;133:e767-e773. doi: 10.1016/j.wneu.2019.09.161. Epub 2019 Oct 9. PMID: 31605843.
Zafar A, Quadri SA, Farooqui M, Ikram A, Robinson M, Hart BL, Mabray MC, Vigil C, Tang AT, Kahn ML, Yonas H, Lawton MT, Kim H, Morrison L. Familial Cerebral Cavernous Malformations. Stroke. 2019 May;50(5):1294-1301. doi: 10.1161/STROKEAHA.118.022314. PMID: 30909834; PMCID: PMC6924279.
Flemming KD, Kumar S, Brown RD Jr, Lanzino G. Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations. World Neurosurg. 2020 Jan;133:e767-e773. doi: 10.1016/j.wneu.2019.09.161. Epub 2019 Oct 9. PMID: 31605843.
Batra S, Lin D, Recinos PF, Zhang J, Rigamondi D. Cavernous Malformations: Natural history, diagnosis and treatment. Nature Rev Neurol, v. 5, n. 12, p. 659-670, Dez. 2009.
Flemming KD, Kumar S, Brown RD Jr, Lanzino G. Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations. World Neurosurg. 2020 Jan;133:e767-e773. doi: 10.1016/j.wneu.2019.09.161. Epub 2019 Oct 9. PMID: 31605843.
Shervin Taslimi, MD, MPH Amirhossein Modabbernia, MD Sepideh Amin- Hanjani,MD, Fred G. Barker II, MDR. Loch Macdonald, MD.: Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies Neurology 2016;86:1984–1991.
Torres G, Kini AT, Al Othman B, Lee AG. Familial Cavernous Hemangioma. J Neuroophthalmol. 2020 Jun;40(2):262-264. doi: 10.1097/WNO.0000000000000778. PMID: 30893269.
Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of Cavernous Angiomas. Lancet Neurol, v. 6, n. 3, p. 237-244, Mar. 2007.
Zafar A, Quadri SA, Farooqui M, Ikram A, Robinson M, Hart BL, Mabray MC, Vigil C, Tang AT, Kahn ML, Yonas H, Lawton MT, Kim H, Morrison L. Familial Cerebral Cavernous Malformations. Stroke. 2019 May;50(5):1294-1301. doi: 10.1161/STROKEAHA.118.022314. PMID: 30909834; PMCID: PMC6924279.
Dalyai RT, Ghobrial G, Awad I, et al. Management of incidental cavernous malformations: a review. Neurosurg Focus. 2011;31(6):E5. doi:10.3171/2011.9.FOCUS11211.
Al Barbarawi MM, Asfour HA, Qudsieh SM, et al. Isolated tectal cavernomas: A comprehensive literature review with a case presentation. Heliyon. 2022;8(4):e09244. Published 2022 Apr 5. doi:10.1016/j.heliyon.2022.e09244
Chen CJ, Ding D, Derdeyn CP, Lanzino G, Friedlander RM, Southerland AM, Lawton MT, Sheehan JP. Brain arteriovenous malformations: A review of natural history, pathobiology, and interventions. Neurology. 2020 Nov 17;95(20):917-927. doi: 10.1212/WNL.0000000000010968. Epub 2020 Oct 1. PMID: 33004601.
Blitstein M & Tung G. MRI of Cerebral Microhemorrhages. AJR Am J Roentgenol. 2007;189(3):720-5. doi:10.2214/ajr.07.2249
Expert Panel on Neurologic Imaging: Salmela MB, Mortazavi S, Jagadeesan BD, Broderick DF, Burns J, Deshmukh TK, Harvey HB, Hoang J, Hunt CH, Kennedy TA, Khalessi AA, Mack W, Patel ND, Perlmutter JS, Policeni B, Schroeder JW, Setzen G, Whitehead MT, Cornelius RS, Corey AS. ACR Appropriateness Criteria®Cerebrovascular Disease. J Am Coll Radiol. 2017 May;14(5S):S34-S61.
Gross BA, Lin N, Du R, Day AL. The natural history of intracranial cavernous malformations. Neurosurg Focus. 2011 Jun;30(6):E24.
Petersen TA, Morrison LA, Schrader RM, Hart BL. Familial versus sporadic cavernous malformations: differences in devel-opmental venous anomaly association and lesion phenotype. AJNR Am J Neuroradiol. 2010 Feb;31(2):377-82.
Dammann P, Wrede K, Zhu Y, Matsushige T, Maderwald S, Umutlu L, Quick HH, Hehr U, Rath M, Ladd ME, Felbor U, Sure U. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI. J Neurosurg. 2017 Feb;126(2):570-577.